The crossroad of science and law

At the Intersection of Science and Law

English - December 16, 2021 19:15 - 26 minutes - 24.1 MB
Life Sciences Science Technology covid19 fda mrna pfizer dlapiper law lawfirms legal pandemic vaccine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Social media’s impact on the life sciences industry

Next Episode: Incentivizing diverse representation in clinical trials

DLA Piper’s Lucas Przymusinski and Raymond Williams are joined by Michael King, Vice President and Associate General Counsel at Jazz Pharmaceuticals, to discuss the benefits of medical and science backgrounds when litigating matters for pharmaceutical and medical device companies.

See omnystudio.com/listener for privacy information.